Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2005
03/03/2005WO2005019474A2 Human autism susceptibility gene and uses thereof
03/03/2005WO2005019471A2 Periostin-like factor: compositions and methods for making and using the same
03/03/2005WO2005019462A1 Nucleotide sequences and polypeptides encoded thereby useful for increasing plant size and increasing the number and size of leaves
03/03/2005WO2005019457A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
03/03/2005WO2005019456A1 Promoter of synoviolin gene
03/03/2005WO2005019455A1 Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
03/03/2005WO2005019454A1 Novel rat calcium channel subunits and related probes, cell lines and methods
03/03/2005WO2005019451A1 Nucleic acid construct for expressing pdk-1 activity inhibitor
03/03/2005WO2005019447A1 Monochromatic fluorescent probe
03/03/2005WO2005019440A1 Methods for enhancing embryo viability
03/03/2005WO2005019432A2 A novel gene and protein associated with angiogenesis and endothelial apoptosis
03/03/2005WO2005019421A2 Crosslinking within coordination complexes
03/03/2005WO2005019420A2 Chimeric receptors with disrupted dileucine motifs
03/03/2005WO2005019414A2 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor
03/03/2005WO2005019411A2 Ancestral viruses and vaccines
03/03/2005WO2005019269A2 Techniques and compositions for the diagnosis and treatment of cancer (muc1)
03/03/2005WO2005019265A1 Improved method of purifying tfpi and tfpi analogs
03/03/2005WO2005019264A2 Human lxr alpha variants
03/03/2005WO2005019263A1 A continuous process for the assembly of macromolecular substances and the subsequent capture and isolation of a macromolecular assembly, and a system suitable for the process
03/03/2005WO2005019262A1 Purification of glucagon-like peptides
03/03/2005WO2005019261A1 Separation of polypeptides comprising a racemized amino acid
03/03/2005WO2005019260A1 INTERFERON-β COMPOSITE
03/03/2005WO2005019259A2 Variants of interleukin-1 receptor antagonist: compositions and uses thereof
03/03/2005WO2005019258A2 Compositions and methods for the treatment of immune related diseases
03/03/2005WO2005019257A1 A protein involved in pancreatic cancer
03/03/2005WO2005019256A2 Muteins of tear lipocalin
03/03/2005WO2005019255A1 Muteins of tear lipocalin
03/03/2005WO2005019254A1 Muteins of a bilin-binding protein with affinity for a given target
03/03/2005WO2005019253A1 Plant-derived peptides harboring water-cleaning and antimicrobial activities
03/03/2005WO2005019252A2 Novel fluorescent and colored proteins, and polynucleotides that encode these proteins
03/03/2005WO2005019250A1 Staphylococcus antibiotic peptides with a broad spectrum of action
03/03/2005WO2005019249A2 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
03/03/2005WO2005019248A1 Hiv immunogenic complexes
03/03/2005WO2005019247A2 Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
03/03/2005WO2005019246A1 Coronavirus vaccines, therapeutics and diagnostics
03/03/2005WO2005019242A2 Recombinant expression of the hag1 antimicrobial peptide: use as fusion partner for the expression of alpha helical antimicrobial peptides
03/03/2005WO2005019239A2 Car ligand-binding domain polypeptide co-crystallized with a ligand, and methods of designing ligands that modulate car activity
03/03/2005WO2005018682A2 Somatostatin analogs with inhibitory activity to growth hormone release
03/03/2005WO2005018673A1 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiocascular disease caused thereby
03/03/2005WO2005018666A1 Polypeptide multimers having antiviral activity
03/03/2005WO2005018663A1 G-csf derivative for inducing immunological tolerance
03/03/2005WO2005018650A2 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
03/03/2005WO2005018575A2 Estrogen receptor modulators and uses thereof
03/03/2005WO2005018554A2 Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy
03/03/2005WO2005018552A2 Heparin binding proteins: sensors for heparin detection
03/03/2005WO2005018542A2 Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects
03/03/2005WO2005018539A2 Influenza hemagglutinin and neuraminidase variants
03/03/2005WO2005018538A2 Severe acute respiratory syndrome (sars) polypeptides, antibodies to sars polypeptides and the use thereof in diagnostic, vaccination and therapeutic applications
03/03/2005WO2005018423A2 Pna oligomers, oligomer sets, methods and kits pertaining to the determination of enterococcus faecalis and other enterococcus species
03/03/2005WO2005018413A2 Methods, kits and antibodies for detecting parathyroid hormone
03/03/2005WO2005018331A1 Neurogenin3 and production of pancreatic islet cells
03/03/2005WO2005010041A3 Regulatory region for xenopus lef-1 expression and its use
03/03/2005WO2005003330A3 Acapsular p. multocida hyae deletion mutants
03/03/2005WO2005000892A3 Glp-1 analog fusion plroteins
03/03/2005WO2005000883A8 Polypeptides having binding affinity for insulin
03/03/2005WO2004111251A3 Modified fiber proteins for efficient receptor binding
03/03/2005WO2004108071A3 Targeting polypeptides to the central nervous system
03/03/2005WO2004105793A3 Soluble clca-1 and antagonists to clca-1
03/03/2005WO2004101612A3 Thioredoxin-peroxidase of c. albicans as a virulence-specific marker
03/03/2005WO2004099254A3 Activation of recombinant diphtheria toxin fusion proteins by specific proteases highly expressed on the surface of tumor cells
03/03/2005WO2004099243A8 Truncated forms of human dbf4, complexes with their interacting partners and methods for identification of inhibitors thereof
03/03/2005WO2004093531A3 Generation of plants with altered oil content
03/03/2005WO2004087956A3 Cell lines for the functional expression of nav1.8
03/03/2005WO2004087054A3 Methods for modulating gastric secretion using prokineticin receptor antagonists.
03/03/2005WO2004080405A3 Igf-binding protein-derived peptide or small molecule
03/03/2005WO2004075835A3 Methods for the treatment of renal cell carcinoma
03/03/2005WO2004073640A3 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
03/03/2005WO2004072269A9 Bex4 nucleic acids, polypeptides, and method of using
03/03/2005WO2004072111A3 Novel therapeutic and diagnostic apoptotic inductors
03/03/2005WO2004070383A3 Identification of pain-regulated gene in the dorsal root ganglion (drg) after cfa-induced arthritis
03/03/2005WO2004060915A3 Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.
03/03/2005WO2004031731A3 Methods for controlling proliferation of cells
03/03/2005WO2004025256A3 Viral deconstruction through capsid assembly in vitro
03/03/2005WO2004019883A3 Tick polypeptides as anticoagulants and vaccines
03/03/2005WO2004005489A3 Nucleic acids encoding sarcocystic neurona antigen and uses thereof
03/03/2005WO2004000876A8 INFECTIOUS cDNA OF AN APPROVED VACCINE STRAIN OF MEASLES VIRUS, USE FOR IMMUNOGENIC COMPOSITIONS
03/03/2005WO2003102013A3 Methods and compositions for production of recombinant peptides
03/03/2005WO2003091418A3 Novel essential fungal polynucleotides, polypeptides, and methods of use
03/03/2005WO2003078458A9 Tap-70, a novel marker for epithelial tumors
03/03/2005WO2003076567A8 Heterologous g-csf fusion proteins
03/03/2005WO2003045317A3 Therapeutic protein and treatments
03/03/2005WO2003042362A3 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
03/03/2005WO2003035846A3 Structure of tall-1 and its cognate receptor
03/03/2005WO2003029401A3 Peptidoglycan recognition protein encoding nucleic acids and methods of use thereof
03/03/2005WO2002062203A9 Compositions and methods for the therapy and diagnosis of breast cancer
03/03/2005US20050050591 Expression vector comprising nucleotide sequences coding mitotic regulatory proteins for use in enhancing formation of lateral organs, growth and yields of plants; tissue engineering and delayed senescence
03/03/2005US20050050590 Floral transition genes in maize and uses thereof
03/03/2005US20050050588 Phloem small RNA binding protein (PSRB) for use in enhancing plant growth, systemic resistance, biomass distribution and flowering
03/03/2005US20050050583 Compositions isolated from plant cells and their use in the modification of plant cell signaling
03/03/2005US20050050581 Expression vector comprising egg white protein regulatory sequences for use as tool in expression of heterologous gene sequences in oviduct cell of avians; tissue engineering; bioreactors
03/03/2005US20050050580 Transgenic animal expressing hla-a24 and utilization thereof
03/03/2005US20050049410 Expression vector comprising nucleotide sequences coding crystal protein for use as tool in controlling plant pest; pesticides; biological pest control
03/03/2005US20050049405 Such as rhodium complexes with apoproteins; for hydrogenation of olefins in water
03/03/2005US20050049399 Expression vector comprising nucleotide sequences coding protein with caspase recruitment domains for use in identifying modulators for treatment and prevention of infection, cell proliferative, inflammatory, autoimmune and nervous system disorders
03/03/2005US20050049398 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
03/03/2005US20050049395 Models of prion disease
03/03/2005US20050049219 Methods of treatment with mini-dystrophin nucleic acid sequences
03/03/2005US20050049218 Kidney or liver fibrosis; using antagonist against the mitogenic vascular endothelial growth factors (zvegf3), such as a monoclonal antibody against zvegf3, receptor binding variants, or antisense agents; antagonist of zvegf3 inhibits cell proliferation
03/03/2005US20050049217 Stimulating the proliferation of kidney tubule epithelial cells in vivo using Zvegf4, a mitogenic multidomain protein with homology to the PDGF/VEGF family of growth factors; platelet-derived growth factor (PDGF); vascular endothelial growth factors (VEGF); renal failure
03/03/2005US20050049216 Immunostimulatory nucleic acid molecules
1 ... 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 ... 2916